...Ahmet Asfuroglu; Melih Balci; Yilmaz Aslan; Cagdas Senel; Ozer Guzel; Muhammed Fevzi Kilinckaya; Turan Turhan; Altug Tuncel Introduction: It was aimed to show the relationship between benign prostatic hyperplasia and inflammation by measuring urinary C-reactive protein values before and after alpha...

... to in the content or advertisements. Appraisal of Guidelines for Research and Evaluation Benign prostate hyperplasia Minimally invasive treatment Guidelines Benign Prostatic Obstruction (BPO) due to Benign Prostatic Hyperplasia (BPH) is one of the most common urological diseases and often requires...

...Eymen Gazel; Engin Kaya; Serdar Yalcin; Halil Çagri Aybal; Tahsin Batuhan Aydogan; Lutfi Tunc Introduction: Holmium laser enucleation of the prostate (HoLEP) is becoming the new standard procedure for treating benign prostatic hyperplasia (BPH), a common condition in aging men. Most studies have...

... benign prostate hyperplasia (BPH), and retrospectively estimating the efficacy and safety of this novel technique. Patients and Methods: Twenty-four BPH patients who underwent PAE and subsequent HoLEP were included. The PAE procedure was performed under local anesthesia at the supine position...

...Kutan Ozer; Mustafa Ozan Horsanali; Sacit Nuri Gorgel; Burcu Ozalp Horsanali; Emin Ozbek Aim: There is a large body of evidence of clinical studies regarding the relation between metabolic syndrome (MetS) and benign prostatic hyperplasia (BPH)-related lower urinary tract symptoms (LUTS) in men...

... symptoms (LUTS) from benign prostate hyperplasia (BPH) [ 1 ]; yet alternate management methods have been developed, including laser enucleation, prostate vaporization, transurethral microwave therapy, transurethral needle ablation, and prostatic stents. These management methods are designed to address...

... and apoptosis and sympathetic nervous systemic activity, whereas endothelial nitric oxide synthase (eNOS) was identified with immunohistochemistry methods as a marker of endothelial activation. Benign prostate hyperplasia Inflammation Simvastatin IL-6 IGF-1 eNOS Ang-II Benign prostatic...

...Longfei Ran; Weiyang He; Xin Zhu; Qingsong Zhou; Xin Gou Introduction: Although transurethral resection of prostate (TURP) remains the reference standard for benign prostate hyperplasia (BPH), the concern about complications promotes researchers to develop alternative surgical methods with fewer...

... acylated and total ghrelin, and obestatin levels in patients with benign prostate hyperplasia (BPH) and PC. Methods: Blood serum concentrations of active and total ghrelin and obestatin were estimated by EIA methods. Results: Serum level of active ghrelin in PC was significantly higher compared to control...

... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Acute retention Benign prostate hyperplasia Modified-release doxazosin Urologia Internationalis Original Paper Urol Int 2008;81:66 71 DOI: 10.1159/000137643 Received: March 8, 2007...

...Michael Froehner; Oliver W. Hakenberg; Rainer Koch; Uta Schmidt; Axel Meye; Manfred P. Wirth Background: To compare the clinical value of the measurement of complex and total PSA in the discrimination between benign prostatic hyperplasia (BPH) and prostate cancer. Methods: In serum samples...

...M. Braun; J. Zumbé; D. Korte; G. Solleder; A. Heidenreich; U. Engelmann Alternative minimally invasive methods treating benign prostate hyperplasia (BPH) have become more and more important. Transurethral needle ablation (TUNA TM) has been demonstrated to be effective in both canine and the human...